» Articles » PMID: 33082392

Toxic Oligomers of the Amyloidogenic HypF-N Protein Form Pores in Mitochondrial Membranes

Overview
Journal Sci Rep
Specialty Science
Date 2020 Oct 21
PMID 33082392
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Studies on the amyloidogenic N-terminal domain of the E. coli HypF protein (HypF-N) have contributed significantly to a detailed understanding of the pathogenic mechanisms in neurodegenerative diseases characterised by the formation of misfolded oligomers, by proteins such as amyloid-β, α-synuclein and tau. Given that both cell membranes and mitochondria are increasingly recognised as key targets of oligomer toxicity, we investigated the damaging effects of aggregates of HypF-N on mitochondrial membranes. Essentially, we found that HypF-N oligomers characterised by high surface hydrophobicity (type A) were able to trigger a robust permeabilisation of mito-mimetic liposomes possessing cardiolipin-rich membranes and dysfunction of isolated mitochondria, as demonstrated by a combination of mitochondrial shrinking, lowering of mitochondrial membrane potential and cytochrome c release. Furthermore, using single-channel electrophysiology recordings we obtained evidence that the type A aggregates induced currents reflecting formation of ion-conducting pores in mito-mimetic planar phospholipid bilayers, with multi-level conductances ranging in the hundreds of pS at negative membrane voltages. Conversely, HypF-N oligomers with low surface hydrophobicity (type B) could not permeabilise or porate mitochondrial membranes. These results suggest an inherent toxicity of membrane-active aggregates of amyloid-forming proteins to mitochondria, and that targeting of oligomer-mitochondrial membrane interactions might therefore afford protection against such damage.

Citing Articles

, inflammation and prion protein binding.

Forloni G, La Vitola P, Balducci C Front Neurosci. 2022; 16:822420.

PMID: 36081661 PMC: 9445368. DOI: 10.3389/fnins.2022.822420.


Dynamics of Amyloid Formation from Simplified Representation to Atomistic Simulations.

Nguyen P, Tuffery P, Derreumaux P Methods Mol Biol. 2022; 2405:95-113.

PMID: 35298810 DOI: 10.1007/978-1-0716-1855-4_5.


Therapeutic Drugs and Devices for Tackling Ocular Hypertension and Glaucoma, and Need for Neuroprotection and Cytoprotective Therapies.

Sharif N Front Pharmacol. 2021; 12:729249.

PMID: 34603044 PMC: 8484316. DOI: 10.3389/fphar.2021.729249.


Quantitative Measurement of the Affinity of Toxic and Nontoxic Misfolded Protein Oligomers for Lipid Bilayers and of its Modulation by Lipid Composition and Trodusquemine.

Errico S, Ramshini H, Capitini C, Canale C, Spaziano M, Barbut D ACS Chem Neurosci. 2021; 12(17):3189-3202.

PMID: 34382791 PMC: 8414483. DOI: 10.1021/acschemneuro.1c00327.


Amyloid Prefibrillar Oligomers: The Surprising Commonalities in Their Structure and Activity.

Diociaiuti M, Bonanni R, Cariati I, Frank C, DArcangelo G Int J Mol Sci. 2021; 22(12).

PMID: 34208561 PMC: 8235680. DOI: 10.3390/ijms22126435.


References
1.
Winner B, Jappelli R, Maji S, Desplats P, Boyer L, Aigner S . In vivo demonstration that alpha-synuclein oligomers are toxic. Proc Natl Acad Sci U S A. 2011; 108(10):4194-9. PMC: 3053976. DOI: 10.1073/pnas.1100976108. View

2.
Kozjak-Pavlovic V, Dian-Lothrop E, Meinecke M, Kepp O, Ross K, Rajalingam K . Bacterial porin disrupts mitochondrial membrane potential and sensitizes host cells to apoptosis. PLoS Pathog. 2009; 5(10):e1000629. PMC: 2759283. DOI: 10.1371/journal.ppat.1000629. View

3.
Zampagni M, Cascella R, Casamenti F, Grossi C, Evangelisti E, Wright D . A comparison of the biochemical modifications caused by toxic and non-toxic protein oligomers in cells. J Cell Mol Med. 2010; 15(10):2106-16. PMC: 4394221. DOI: 10.1111/j.1582-4934.2010.01239.x. View

4.
Liu Y, Ren B, Zhang Y, Sun Y, Chang Y, Liang G . Molecular simulation aspects of amyloid peptides at membrane interface. Biochim Biophys Acta Biomembr. 2018; 1860(9):1906-1916. DOI: 10.1016/j.bbamem.2018.02.004. View

5.
Horvath S, Daum G . Lipids of mitochondria. Prog Lipid Res. 2013; 52(4):590-614. DOI: 10.1016/j.plipres.2013.07.002. View